000 | 01226 a2200409 4500 | ||
---|---|---|---|
005 | 20250513191912.0 | ||
264 | 0 | _c19990915 | |
008 | 199909s 0 0 eng d | ||
022 | _a0009-9147 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRubinacci, A | |
245 | 0 | 0 |
_aTotal and free deoxypyridinoline after acute osteoclast activity inhibition. _h[electronic resource] |
260 |
_bClinical chemistry _cSep 1999 |
||
300 |
_a1510-6 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAmino Acids _xmetabolism |
650 | 0 | 4 |
_aBiomarkers _xurine |
650 | 0 | 4 |
_aBone Resorption _xurine |
650 | 0 | 4 | _aCalcium |
650 | 0 | 4 | _aChromatography, High Pressure Liquid |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunoassay |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aOsteoclasts _xmetabolism |
650 | 0 | 4 |
_aPeptides _xmetabolism |
650 | 0 | 4 | _aProtein Binding |
650 | 0 | 4 | _aSensitivity and Specificity |
700 | 1 | _aMelzi, R | |
700 | 1 | _aZampino, M | |
700 | 1 | _aSoldarini, A | |
700 | 1 | _aVilla, I | |
773 | 0 |
_tClinical chemistry _gvol. 45 _gno. 9 _gp. 1510-6 |
|
999 |
_c10429158 _d10429158 |